Investigation of obesity-related HAdV-36 in NAFLD patients: A case-control study

Basit Öğe Kaydı
dc.authorid0000-0001-7275-8724
dc.contributor.authorDinç, Harika Öykü
dc.contributor.authorÇizmecigil, Utku
dc.contributor.authorSulu, Cem
dc.contributor.authorYıldırım, Süleyman
dc.contributor.authorTurgut, Başar C.
dc.contributor.authorSirekbasan, Serhat
dc.contributor.authorAydoğan, Okan
dc.contributor.authorDurman, Tunahan
dc.contributor.authorÖzbey, Doğukan
dc.contributor.authorAslan, Beyza
dc.contributor.authorSonsuz, Abdullah
dc.contributor.authorZengin, Kağan
dc.contributor.authorYumuk, Volkan Demirhan
dc.contributor.authorYılmaz, Aysun
dc.contributor.authorTuran, Nuri
dc.contributor.authorYılmaz, Hüseyin
dc.contributor.authorTufan Koçak, Banu
dc.contributor.authorSarıbaş, Suat
dc.contributor.authorErgin, Sevgi
dc.contributor.authorKocazeybek, Bekir
dc.date.accessioned2023-05-31T11:42:20Z
dc.date.available2023-05-31T11:42:20Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Mikrobiyoloji Ana Bilim Dalı
dc.description.abstractBackground: HAdV-36 leads to adipocyte proliferation of adipose tissue through E4orf1 gene, leading to the development of obesity and related diseases. We aimed to investigate the presence and any association of HAdV-36 in non-alcoholic fatty liver disease (NAFLD) patients Methods: The patient group was composed of 116 patients; 30 obese patients with NAFLD (BMI > 30 kg/m2), 30 patients with Diabetes Mellitus (DM)+NAFLD (BMI > 30 kg/m2), 16 patients with NAFLD (BMI < 30 kg/m2), and operated obese group with NAFLD (BMI > 30 kg/m2). The control group comprised 81 non-obese healthy adults. Liver adipose tissue samples were obtained in 30 operated NAFLD patients. HAdV-36-DNA, HAdV-36 neutralizing antibodies, serum lipid, and adipokine levels were analyzed. Results: HAdV-36 neutralizing antibodies (HAdV-36 Ab-positive) were detected in 10/116 and 2/81 participants in the study and control groups, respectively; the difference was statistically significant (p < 0.005). LDL, total cholesterol but not adipokine levels were found to be significantly higher in HadV-36 Ab-positive patients (p < 0.05). While HAdV-36 was identified as a risk factor with OR = 4.11 in univariate analyses, there was no significant difference in binary logistic regression analysis. HAdV-36-DNA was detected in the adipose tissue samples of two patients. Conclusions: We suggest that the presence of HAdV-36 may lead to the development of obesity with the increase in adipose tissue, and diseases such as hyperlipidemia, NAFLD, DM, and metabolic syndrome may develop on the basis of chronic inflammation caused by obesity. Thus, HAdV-36 may be a plausible risk factor for the development of NAFLD.
dc.description.sponsorshipIstanbul University-Cerrahpaşa Scientific Research Projects Uniten_US
dc.identifier.citationDinç, H. Ö., Çizmecigil, U., Sulu, C., Yıldırım, S., Turgut, B. C., Sirekbasan, S. ... Kocazeybek, B. (2023). Investigation of obesity-related HAdV-36 in NAFLD patients: A case-control study. Clinical Laboratory, 69(1), 172-178. https://doi.org/10.7754/Clin.Lab.2022.221031
dc.identifier.doi10.7754/Clin.Lab.2022.221031
dc.identifier.endpage178
dc.identifier.issn1433-6510
dc.identifier.issue1
dc.identifier.pmid36649529
dc.identifier.scopus2-s2.0-85146404179
dc.identifier.scopusqualityQ3
dc.identifier.startpage172
dc.identifier.urihttps://doi.org/10.7754/Clin.Lab.2022.221031
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11003
dc.identifier.volume69
dc.identifier.wos000913528000001en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorAydoğan, Okan
dc.language.isoen
dc.publisherVerlag Klinisches Labor GmbH
dc.relation.ispartofClinical Laboratoryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHAdV-36
dc.subjectHAdV-36 DNA
dc.subjectNAFLD
dc.subjectObesity
dc.subjectSerum Neutralizing
dc.titleInvestigation of obesity-related HAdV-36 in NAFLD patients: A case-control study
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu